PES CON 2019 vs Appointer Provider
Price, ratings, monetisation and update history for both apps, side by side ā with what reviewers say about each.
PES CON 2019
Read full descriptionHide full description
Pakistan Endocrine Society has come a long way, from a handful of endocrinologists to over seventy formally qualified and trained endocrinologists as active executive members.
Appointer Provider
Read full descriptionHide full description
Appointer Provider is the all-in-one app for doctors, clinics, and practice assistants. Manage your appointment queue and live tokens, run consultations, and write prescriptions, diagnoses, vitals, and lab orders straight into the patient record. Track fees and equity per clinic, manage your panels and timings, and use AI-assisted consultation tools to save time. ⢠Live appointment queue and token management ⢠Consultation workflow with EHR (prescriptions, diagnosis, vitals, labs) ⢠AI-assisted consult and clinical notes ⢠Multi-clinic panels, timings, and fee tracking ⢠Real-time notifications ⢠Sign in with Apple, Google, phone, or email
Screenshots
Verdict
The clearest difference is iOS requirement: PES CON 2019 at 9.0 against Appointer Provider's 15.0. On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price Ā· Rating Ā· Positive reviews Ā· Number of ratings Ā· Update frequency Ā· Ads Ā· In-app purchases Ā· Monetization Ā· Best chart rank Ā· Devices Ā· Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
| Parameter | PES CON 2019 | Appointer Provider |
|---|---|---|
| Price | Free | Free |
| Update frequency | ā | Every 2 days |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 9.0 ā better | 15.0 |
| Further details ā not scored | ||
| Size | 34 MB | 35 MB |
| Age rating | 4+ | 17+ |
| Developer | PHARMEVO PRIVATE LIMITED | Quaid Technologies Ltd |
In-app purchases
PES CON 2019
No in-app purchases
Appointer Provider
No in-app purchases







